Product Information for Veterinary Healthcare Professionals
A vaccine for active immunisation of dogs against Bordetella bronchiseptica to reduce clinical signs of upper respiratory tract disease and bacterial shedding post infection. Infectious tracheobronchitis is a highly contagious, multi-factorial disease of the dog’s respiratory tract. Bordetella bronchiseptica is the most common bacterial agent associated with the disease. Environmental factors such as stress, ventilation and climate may also contribute.
Nobivac Respira is an easy-to-administer vaccine for subcutaneous injection which acts against this key causative agent of infectious tracheobronchitis and provides protection within 2 weeks and lasts for at least 7-12 months, depending on whether, or not, the animal was previously vaccinated with the MSD Animal Health intranasal vaccine. It can be used in puppies as young as six weeks and in pregnant bitches (though its use has not been investigated during the first 20 days of gestation). For uses, dosage, contra-indications and warnings please consult product leaflet. Further information is available on request. Use medicines responsibly.
Multi-dose vial containing 10 doses (in-use shelf life 4 weeks). Cartons of 5 single dose pre-filled syringes. Not all pack sizes may be marketed. The product is not yet available.
Summary of Product Characteristics
For Summary of Product Characteristics, first click on this link. Then type in Nobivac Respira in Product name field. Click on Run search. Subsequently click on View SPC on line listing opposite Nobivac Respira.